Sector: Biotechnology - Other
Technological Field: Drug discovery
Year Established: 2011
Pepticom Ltd. is an Israeli innovative computational drug discovery company founded on December 2011, privately co-owned by the Hebrew University of Jerusalem, seed investors and the scientific team that developed Pepticom's unique technology.
Description of activities:
To date we have launched several research projects aimed at the discovery of innovative peptides and small-molecule drug candidates for cancer, immunology, cardiovascular and central nervous system diseases (including two EUREKA label projects). The programs are carried out either in-house or in collaboration with a network of leading universities, renowned research institutes and CROs. As our programs gain momentum and are to reach preclinical development within the next year we are open to mutually beneficial partnering opportunities.